Two Oral Trofosfamide Schedules in Elderly Patients with Refractory Non-Hodgkin‘s Lymphoma

Publisher： Karger

E-ISSN： 2296-5262|22|2|134-138

ISSN： 2296-5270

Source： Oncology Research and Treatment, Vol.22, Iss.2, 1999-05, pp. : 134-138

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Individualized Liposomal Doxorubicin-Based Treatment in Elderly Patients with Non-Hodgkin’s Lymphoma

By  

Oncology Research and Treatment, Vol. 34, Iss. 4, 2011-03 ,pp. : 184-188

Karger

Access to resources Recommend Favorite

Prospective Randomized Study Comparing MEMID with a Chop-Like Regimen in Elderly Patients with Aggressive Non-Hodgkin’s Lymphoma

By  

Oncology, Vol. 69, Iss. 1, 2005-09 ,pp. : 19-26

Karger

Access to resources Recommend Favorite

Long-Term Administration of Oral Low-Dose Topoisomerase II Inhibitors, MST-16 and VP-16, for Refractory or Relapsed Non-Hodgkin’s Lymphoma

By  

Acta Haematologica, Vol. 104, Iss. 2-3, 2001-01 ,pp. : 128-130

Karger

Access to resources Recommend Favorite

Antibody Therapy with Rituximab for Patients with Low-Grade Non-Hodgkin’s Lymphoma

By  

Oncology Research and Treatment, Vol. 22, Iss. 3, 1999-07 ,pp. : 184-190

Karger

Access to resources Recommend Favorite

Is Bone Marrow Biopsy Obligatory in All Patients with Non-Hodgkin’s Lymphoma?

By  

Acta Haematologica, Vol. 118, Iss. 1, 2007-05 ,pp. : 61-64

Karger

Access to resources Recommend Favorite